Main Article Content



Cataract is the major preventable cause of blindness. In India 50-80% of blindness is due to cataract. Recent data from World Health Organization (WHO) shows 25% decrease in blindness prevalence in India. Cataract surgery has been viewed as one of the most cost effective health interventions with a cost of disability adjusted life years saved each year being  20-40 $ (1200-1800 Indian Rs). There has been a substantial rise in cataract surgeries in recent years leading to increased utilization of drugs. Studies about pattern of drugs used in cataract patients are sparse in India. Hence the above study was taken up.


To analyze drug utilization in post cataract surgery patients based on WHO indicators.

Materials and methods

Across-sectional, observational study was conducted over a duration of 6 months at department of ophthalmology, Minto Eye Hospital, Bengaluru. A total of 110 prescriptions were analyzed who visited in-patient department. The data was analyzed by descriptive statistics.


A total of 110 prescriptions were analyzed which included 431 drugs. Average number of drugs per prescription was 3.91, among which five drugs per prescription were maximum (41%). Majority of the drugs prescribed were in the form of eye drops (65.08%) and the commonest FDC eye drops prescribed being ciprofloxacin with dexamethasone (13.68%). Percentage of prescription with antibiotic is (52%) and injections were (0.89%). About (94.54%) of the drugs were prescribed by brand name and only (5.4%) by generic name. Percentage of drugs prescribed from essential drug list (72.92%). Commonly prescribed drugs were Antimicrobials (52%), Analgesic (23%), Steroid (7%), FDCs (10%), Mydriatics (4%) and others (4%).


Topical drugs were commonly prescribed to treat ocular infections. Evaluation of drugs using WHO core prescribing indicators showed that the number of drugs prescribed by generic names and from NLEM was low. 


Drug Utilization Cataract Core indicators WHO Generic names

Article Details

How to Cite
Divya K, Jayanthi C R, & Nagaraju G. (2021). Drug utilization study in post cataract surgery patients in a tertiary care hospital. International Journal of Research in Pharmacology & Pharmacotherapeutics, 7(1), 61-68. Retrieved from


  1. [1]. Thulasiraj RD, Rahamathulla R, Saraswati A, Selvaraj S, Ellwein LB. The Sivaganga eye survey: I. Blindness and cataract surgery. Ophthalmic Epidemiol 9, 2002, 299-312.
  2. [2]. Nirmalan PK, Thulasiraj RD, Maneksha V, Rahmathullah R, Ramakrishnan R, Padmavathi A, et al. A population based eye survey of older adults in Tirunelveli district of south India: Blindness, cataract surgery and visual outcomes. Br J Ophthalmol 86, 2002, 505-12.
  3. [3]. Murthy GV, Gupta S, Ellwein LB, Munoz SR, Bachani D, Dada VK. A population-based eye survey of older adults in a rural district of Rajasthan: I. Central vision impairment, blindness and cataract surgery. Ophthalmology 108, 2001, 679-85.
  4. [4]. Mohan M. National survey of blindness-India. NPCB-WHO Report. New Delhi: Ministry of Health and Family Welfare, Government of India; 1989.
  5. [5]. World Health Organization. Global initiative for the elimination of avoidable blindness: An informal consultation. Geneva: WHO; 1997.
  6. [6]. Government of India Annual Report 2003-4 Ministry of Health and Family Welfare, New Delhi.
  7. [7]. Cho H, Wolf KJ, Wolf EJ. Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution. ClinOphthalmol., 199(3), 2009, 210.
  8. [8]. World Health Organization, Introduction to Drug Utilization Research, WHO, Oslo, Norway, 2003.
  9. [9]. Nepalese National Formulary. 1st Edition. Nepal: Kathmandu Nepal Ministry of Health; 1997.
  10. [10]. Suman RK, Deshmukh YA, Ray I, Gore VS. Drug utilization studies in glaucoma patients at MGM Medical College and Hospital. Int J Sci Res. 7(2), 2013, 433-5.
  11. [11]. Lalan KB, Ghongane BB. Drug prescription pattern of out-patients in a tertiary teaching hospital in Maharastra. Int J Pharm Bio Sci. 3(3), 2012, 225-229.
  12. [12]. How to Investigate Drug Use in HealthFacilities: Selected Drug Use indicators. WHO, Geneva, Switzerland, 1993 [cited on 2017]. Available from: URL:
  13. [13]. Mainirajiv,Vermakk, Biswas NR. Drug utilization study in Dermatology in a tertiary care hospital in Delhi. Ind J PhysiolPharmacol. 46, 2002, 107-10.
  14. [14]. Abidi A, Gupta S, Kansal S, Ramgopal. Prescription auditing and drug utilization pattern in a tertiary care teaching hospital of western UP. Int J Basic ClinPharmacol. 1(3), 2012, 184-190.
  15. [15]. How to Investigate Drug Use in HealthFacilities: Selected Drug Use indicators. WHO, Geneva, Switzerland, 1993 [cited on 2017]. Available from: URL:
  16. [16]. Jadhav PR, Moghe VV, Deshmukh YA. Drug utilization study in ophthalmology outpatients at a tertiary care teaching hospital. ISRN Pharmacol. 2013, 2013, 768-792.
  17. [17]. Rajesh kumarSuman, YA Deshmukh, Ipseeta Ray Mohanty, Varshav S. Gore. Drug Utilization studies in Glaucoma Patients at MGM medical college and Hospital. Int J of Sci research 2(7), 2013, 433-435.
  18. [18]. PoojaPrajwal. Assessment of the prescription in cataract patients for the Drug Utilization Pattern. International journal of advances in pharmaceutical research 4(10), 2013.
  19. [19]. Bhavikkumar HS, Bhavin V. Divyesh JV, Jasmina SS. Drug utilization Study in cataract Patients from South Gujrat region. Indian Journal of Pharmacy Practice 4(3), 2011, 46-50.
  20. [20]. In: Goodman L, Gilman A, Brunton L, Lazo J, Parker K, editors. The pharmacological basis of therapeutics. New York: McGraw-Hill; 12, 2011, 947-948.
  21. [21]. Banerjee I, Bhadury T, Sengupta T, Roy D. Drug utilization study in ophthalmology out-patients department of a medical college in India. Ann Med Health Sci Res. 4(4), 2014, 667-670.
  22. [22]. Ashish G, Rashmi S, Sujata S, Sharma BD. Pharmacoepidemology of drugs utilized in ophthalmic outpatient and inpatient department of a tertiary care hospital. Journal of Applied Pharmaceutical Science. 1(9), 2011, 135-140.
  23. [23]. Rataboli PV, Garg A. Confusing brand names: Nightmare of medical profession. J Postgraduate Medicine. 51(1), 2005, 13-16.
  24. [24]. The Selection and Use of Essential Medicines. WHO Technical Report Series, 2003, 914. [Cited on 2017]. Available from: URL: